nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—RARB—lung cancer	0.765	1	CbGaD
Tazarotene—Localised oedema—Crizotinib—lung cancer	0.0079	0.0859	CcSEcCtD
Tazarotene—CYP2C8—Erlotinib—lung cancer	0.00415	0.379	CbGbCtD
Tazarotene—RARA—mammary gland—lung cancer	0.00382	0.129	CbGeAlD
Tazarotene—CYP2C8—Paclitaxel—lung cancer	0.0038	0.347	CbGbCtD
Tazarotene—RARB—respiratory system—lung cancer	0.00332	0.112	CbGeAlD
Tazarotene—CYP2C8—Etoposide—lung cancer	0.003	0.274	CbGbCtD
Tazarotene—Burning sensation—Crizotinib—lung cancer	0.00287	0.0312	CcSEcCtD
Tazarotene—RARB—bronchus—lung cancer	0.00273	0.0925	CbGeAlD
Tazarotene—RARG—respiratory system—lung cancer	0.00271	0.0917	CbGeAlD
Tazarotene—Pain of skin—Paclitaxel—lung cancer	0.00267	0.0291	CcSEcCtD
Tazarotene—RARA—respiratory system—lung cancer	0.00255	0.0862	CbGeAlD
Tazarotene—Localised oedema—Paclitaxel—lung cancer	0.00249	0.0271	CcSEcCtD
Tazarotene—Acne—Gefitinib—lung cancer	0.00215	0.0234	CcSEcCtD
Tazarotene—RXRB—cardiac atrium—lung cancer	0.00212	0.0717	CbGeAlD
Tazarotene—Skin hyperpigmentation—Erlotinib—lung cancer	0.00182	0.0198	CcSEcCtD
Tazarotene—RARB—lung—lung cancer	0.00176	0.0597	CbGeAlD
Tazarotene—Skin exfoliation—Pemetrexed—lung cancer	0.00174	0.0189	CcSEcCtD
Tazarotene—RXRB—lung—lung cancer	0.00162	0.0549	CbGeAlD
Tazarotene—CYP2C8—mammary gland—lung cancer	0.00151	0.0513	CbGeAlD
Tazarotene—Blister—Erlotinib—lung cancer	0.0015	0.0163	CcSEcCtD
Tazarotene—RARA—bone marrow—lung cancer	0.00149	0.0505	CbGeAlD
Tazarotene—RARG—lung—lung cancer	0.00144	0.0487	CbGeAlD
Tazarotene—Dermatitis bullous—Gefitinib—lung cancer	0.00138	0.015	CcSEcCtD
Tazarotene—RARA—lung—lung cancer	0.00135	0.0458	CbGeAlD
Tazarotene—Blister—Vinorelbine—lung cancer	0.0013	0.0141	CcSEcCtD
Tazarotene—Acne—Erlotinib—lung cancer	0.00129	0.014	CcSEcCtD
Tazarotene—RARB—lymph node—lung cancer	0.00121	0.0408	CbGeAlD
Tazarotene—Dry skin—Gefitinib—lung cancer	0.00121	0.0131	CcSEcCtD
Tazarotene—Inflammation—Erlotinib—lung cancer	0.00112	0.0121	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Paclitaxel—lung cancer	0.00106	0.0115	CcSEcCtD
Tazarotene—Skin exfoliation—Erlotinib—lung cancer	0.00103	0.0112	CcSEcCtD
Tazarotene—Oedema peripheral—Crizotinib—lung cancer	0.000987	0.0107	CcSEcCtD
Tazarotene—RARG—lymph node—lung cancer	0.000984	0.0333	CbGeAlD
Tazarotene—Sensitisation—Doxorubicin—lung cancer	0.000933	0.0101	CcSEcCtD
Tazarotene—RARA—lymph node—lung cancer	0.000925	0.0313	CbGeAlD
Tazarotene—Haemoglobin—Gefitinib—lung cancer	0.000915	0.00994	CcSEcCtD
Tazarotene—Haemorrhage—Gefitinib—lung cancer	0.00091	0.00989	CcSEcCtD
Tazarotene—Leukoderma—Methotrexate—lung cancer	0.000905	0.00984	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Docetaxel—lung cancer	0.000898	0.00976	CcSEcCtD
Tazarotene—Oedema peripheral—Gefitinib—lung cancer	0.000896	0.00974	CcSEcCtD
Tazarotene—Skin exfoliation—Vinorelbine—lung cancer	0.000894	0.00972	CcSEcCtD
Tazarotene—Dermatitis bullous—Topotecan—lung cancer	0.000832	0.00904	CcSEcCtD
Tazarotene—Dermatitis bullous—Erlotinib—lung cancer	0.000823	0.00894	CcSEcCtD
Tazarotene—Erythema—Pemetrexed—lung cancer	0.000797	0.00867	CcSEcCtD
Tazarotene—Leukoderma—Doxorubicin—lung cancer	0.000784	0.00852	CcSEcCtD
Tazarotene—Burning sensation—Docetaxel—lung cancer	0.000769	0.00836	CcSEcCtD
Tazarotene—Haemoglobin—Teniposide—lung cancer	0.000746	0.00811	CcSEcCtD
Tazarotene—Haemorrhage—Teniposide—lung cancer	0.000742	0.00806	CcSEcCtD
Tazarotene—Dry skin—Erlotinib—lung cancer	0.000721	0.00784	CcSEcCtD
Tazarotene—Skin exfoliation—Gemcitabine—lung cancer	0.000718	0.00781	CcSEcCtD
Tazarotene—Oedema—Crizotinib—lung cancer	0.000712	0.00774	CcSEcCtD
Tazarotene—Dermatitis bullous—Vinorelbine—lung cancer	0.000711	0.00773	CcSEcCtD
Tazarotene—Skin discolouration—Etoposide—lung cancer	0.000711	0.00773	CcSEcCtD
Tazarotene—Skin discolouration—Paclitaxel—lung cancer	0.000697	0.00758	CcSEcCtD
Tazarotene—Skin exfoliation—Cisplatin—lung cancer	0.00067	0.00728	CcSEcCtD
Tazarotene—Inflammation—Etoposide—lung cancer	0.000662	0.0072	CcSEcCtD
Tazarotene—Oedema—Pemetrexed—lung cancer	0.000651	0.00707	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Methotrexate—lung cancer	0.000647	0.00703	CcSEcCtD
Tazarotene—Skin exfoliation—Etoposide—lung cancer	0.000613	0.00667	CcSEcCtD
Tazarotene—Skin exfoliation—Paclitaxel—lung cancer	0.000601	0.00654	CcSEcCtD
Tazarotene—Dermatitis bullous—Gemcitabine—lung cancer	0.000571	0.00621	CcSEcCtD
Tazarotene—Haemoglobin—Vinblastine—lung cancer	0.000569	0.00618	CcSEcCtD
Tazarotene—Haemorrhage—Vinblastine—lung cancer	0.000566	0.00615	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Doxorubicin—lung cancer	0.00056	0.00609	CcSEcCtD
Tazarotene—Pain—Pemetrexed—lung cancer	0.000556	0.00605	CcSEcCtD
Tazarotene—Burning sensation—Methotrexate—lung cancer	0.000554	0.00602	CcSEcCtD
Tazarotene—Pain—Gefitinib—lung cancer	0.000553	0.00601	CcSEcCtD
Tazarotene—Haemoglobin—Topotecan—lung cancer	0.000553	0.00601	CcSEcCtD
Tazarotene—Inflammation—Docetaxel—lung cancer	0.00055	0.00598	CcSEcCtD
Tazarotene—Haemorrhage—Topotecan—lung cancer	0.00055	0.00598	CcSEcCtD
Tazarotene—Haemoglobin—Erlotinib—lung cancer	0.000547	0.00594	CcSEcCtD
Tazarotene—Haemorrhage—Erlotinib—lung cancer	0.000544	0.00591	CcSEcCtD
Tazarotene—Swelling—Etoposide—lung cancer	0.000529	0.00575	CcSEcCtD
Tazarotene—Oedema—Teniposide—lung cancer	0.000527	0.00573	CcSEcCtD
Tazarotene—Swelling—Paclitaxel—lung cancer	0.000518	0.00564	CcSEcCtD
Tazarotene—Skin exfoliation—Docetaxel—lung cancer	0.00051	0.00554	CcSEcCtD
Tazarotene—Burning sensation—Doxorubicin—lung cancer	0.00048	0.00521	CcSEcCtD
Tazarotene—Erythema—Erlotinib—lung cancer	0.000474	0.00515	CcSEcCtD
Tazarotene—Blister—Doxorubicin—lung cancer	0.000462	0.00503	CcSEcCtD
Tazarotene—Pruritus—Pemetrexed—lung cancer	0.00046	0.005	CcSEcCtD
Tazarotene—Pruritus—Gefitinib—lung cancer	0.000457	0.00497	CcSEcCtD
Tazarotene—Rash—Crizotinib—lung cancer	0.000449	0.00488	CcSEcCtD
Tazarotene—Dermatitis—Crizotinib—lung cancer	0.000448	0.00488	CcSEcCtD
Tazarotene—Swelling—Docetaxel—lung cancer	0.000439	0.00478	CcSEcCtD
Tazarotene—Skin discolouration—Methotrexate—lung cancer	0.000426	0.00463	CcSEcCtD
Tazarotene—Dry skin—Paclitaxel—lung cancer	0.000419	0.00456	CcSEcCtD
Tazarotene—Discomfort—Vinblastine—lung cancer	0.000414	0.00451	CcSEcCtD
Tazarotene—Stinging—Doxorubicin—lung cancer	0.000411	0.00447	CcSEcCtD
Tazarotene—Rash—Pemetrexed—lung cancer	0.00041	0.00446	CcSEcCtD
Tazarotene—Dermatitis—Pemetrexed—lung cancer	0.00041	0.00446	CcSEcCtD
Tazarotene—Erythema—Vinorelbine—lung cancer	0.000409	0.00445	CcSEcCtD
Tazarotene—Rash—Gefitinib—lung cancer	0.000408	0.00443	CcSEcCtD
Tazarotene—Dermatitis—Gefitinib—lung cancer	0.000407	0.00443	CcSEcCtD
Tazarotene—Dermatitis bullous—Docetaxel—lung cancer	0.000406	0.00441	CcSEcCtD
Tazarotene—Discomfort—Topotecan—lung cancer	0.000403	0.00438	CcSEcCtD
Tazarotene—Inflammation—Methotrexate—lung cancer	0.000397	0.00431	CcSEcCtD
Tazarotene—Haemoglobin—Irinotecan—lung cancer	0.00039	0.00424	CcSEcCtD
Tazarotene—Haemorrhage—Irinotecan—lung cancer	0.000388	0.00422	CcSEcCtD
Tazarotene—Oedema—Erlotinib—lung cancer	0.000386	0.0042	CcSEcCtD
Tazarotene—Haemoglobin—Gemcitabine—lung cancer	0.00038	0.00413	CcSEcCtD
Tazarotene—Haemorrhage—Gemcitabine—lung cancer	0.000378	0.00411	CcSEcCtD
Tazarotene—Pruritus—Teniposide—lung cancer	0.000373	0.00405	CcSEcCtD
Tazarotene—Oedema peripheral—Gemcitabine—lung cancer	0.000372	0.00405	CcSEcCtD
Tazarotene—Skin discolouration—Doxorubicin—lung cancer	0.000369	0.00401	CcSEcCtD
Tazarotene—Skin exfoliation—Methotrexate—lung cancer	0.000367	0.00399	CcSEcCtD
Tazarotene—Photosensitivity reaction—Paclitaxel—lung cancer	0.000361	0.00392	CcSEcCtD
Tazarotene—Dry skin—Docetaxel—lung cancer	0.000355	0.00386	CcSEcCtD
Tazarotene—Discomfort—Vinorelbine—lung cancer	0.000344	0.00374	CcSEcCtD
Tazarotene—Pain—Vinblastine—lung cancer	0.000344	0.00374	CcSEcCtD
Tazarotene—Inflammation—Doxorubicin—lung cancer	0.000344	0.00373	CcSEcCtD
Tazarotene—Pain—Topotecan—lung cancer	0.000334	0.00363	CcSEcCtD
Tazarotene—Rash—Teniposide—lung cancer	0.000332	0.00361	CcSEcCtD
Tazarotene—Dermatitis—Teniposide—lung cancer	0.000332	0.00361	CcSEcCtD
Tazarotene—Pain—Erlotinib—lung cancer	0.00033	0.00359	CcSEcCtD
Tazarotene—Dermatitis contact—Doxorubicin—lung cancer	0.000329	0.00358	CcSEcCtD
Tazarotene—Erythema—Gemcitabine—lung cancer	0.000329	0.00358	CcSEcCtD
Tazarotene—Skin exfoliation—Doxorubicin—lung cancer	0.000318	0.00346	CcSEcCtD
Tazarotene—Haemoglobin—Paclitaxel—lung cancer	0.000318	0.00346	CcSEcCtD
Tazarotene—Haemorrhage—Paclitaxel—lung cancer	0.000316	0.00344	CcSEcCtD
Tazarotene—Oedema peripheral—Paclitaxel—lung cancer	0.000312	0.00339	CcSEcCtD
Tazarotene—Erythema—Cisplatin—lung cancer	0.000307	0.00333	CcSEcCtD
Tazarotene—Pain—Vinorelbine—lung cancer	0.000286	0.00311	CcSEcCtD
Tazarotene—Discomfort—Irinotecan—lung cancer	0.000284	0.00309	CcSEcCtD
Tazarotene—Discomfort—Gemcitabine—lung cancer	0.000277	0.00301	CcSEcCtD
Tazarotene—Pruritus—Topotecan—lung cancer	0.000276	0.003	CcSEcCtD
Tazarotene—Oedema—Irinotecan—lung cancer	0.000276	0.003	CcSEcCtD
Tazarotene—Erythema—Paclitaxel—lung cancer	0.000275	0.00299	CcSEcCtD
Tazarotene—Pruritus—Erlotinib—lung cancer	0.000273	0.00297	CcSEcCtD
Tazarotene—Haemoglobin—Docetaxel—lung cancer	0.000269	0.00293	CcSEcCtD
Tazarotene—Eczema—Doxorubicin—lung cancer	0.000269	0.00293	CcSEcCtD
Tazarotene—Oedema—Gemcitabine—lung cancer	0.000268	0.00292	CcSEcCtD
Tazarotene—Haemorrhage—Docetaxel—lung cancer	0.000268	0.00292	CcSEcCtD
Tazarotene—Oedema peripheral—Docetaxel—lung cancer	0.000264	0.00287	CcSEcCtD
Tazarotene—Discomfort—Cisplatin—lung cancer	0.000258	0.0028	CcSEcCtD
Tazarotene—Dermatitis bullous—Doxorubicin—lung cancer	0.000253	0.00275	CcSEcCtD
Tazarotene—Oedema—Cisplatin—lung cancer	0.00025	0.00272	CcSEcCtD
Tazarotene—Rash—Topotecan—lung cancer	0.000246	0.00268	CcSEcCtD
Tazarotene—Dermatitis—Topotecan—lung cancer	0.000246	0.00268	CcSEcCtD
Tazarotene—Rash—Erlotinib—lung cancer	0.000244	0.00265	CcSEcCtD
Tazarotene—Dermatitis—Erlotinib—lung cancer	0.000243	0.00265	CcSEcCtD
Tazarotene—Pruritus—Vinorelbine—lung cancer	0.000236	0.00257	CcSEcCtD
Tazarotene—Discomfort—Etoposide—lung cancer	0.000236	0.00257	CcSEcCtD
Tazarotene—Pain—Irinotecan—lung cancer	0.000236	0.00256	CcSEcCtD
Tazarotene—Erythema—Docetaxel—lung cancer	0.000233	0.00254	CcSEcCtD
Tazarotene—Discomfort—Paclitaxel—lung cancer	0.000232	0.00252	CcSEcCtD
Tazarotene—Pain—Gemcitabine—lung cancer	0.00023	0.0025	CcSEcCtD
Tazarotene—Oedema—Paclitaxel—lung cancer	0.000225	0.00244	CcSEcCtD
Tazarotene—Dry skin—Doxorubicin—lung cancer	0.000222	0.00241	CcSEcCtD
Tazarotene—Photosensitivity reaction—Methotrexate—lung cancer	0.00022	0.0024	CcSEcCtD
Tazarotene—Pain—Cisplatin—lung cancer	0.000214	0.00233	CcSEcCtD
Tazarotene—Rash—Vinorelbine—lung cancer	0.000211	0.00229	CcSEcCtD
Tazarotene—Dermatitis—Vinorelbine—lung cancer	0.00021	0.00229	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	0.000197	0.00192	CbGpPWpGaD
Tazarotene—Pain—Etoposide—lung cancer	0.000196	0.00213	CcSEcCtD
Tazarotene—Haemoglobin—Methotrexate—lung cancer	0.000194	0.00211	CcSEcCtD
Tazarotene—Haemorrhage—Methotrexate—lung cancer	0.000193	0.0021	CcSEcCtD
Tazarotene—Pain—Paclitaxel—lung cancer	0.000192	0.00209	CcSEcCtD
Tazarotene—Photosensitivity reaction—Doxorubicin—lung cancer	0.000191	0.00207	CcSEcCtD
Tazarotene—RARG—Gene Expression—KHSRP—lung cancer	0.000191	0.00186	CbGpPWpGaD
Tazarotene—Oedema—Docetaxel—lung cancer	0.00019	0.00207	CcSEcCtD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.00019	0.00186	CbGpPWpGaD
Tazarotene—Pruritus—Gemcitabine—lung cancer	0.00019	0.00206	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—NPPA—lung cancer	0.00019	0.00185	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—RB1—lung cancer	0.000189	0.00185	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	0.000189	0.00184	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000188	0.00183	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HNRNPA2B1—lung cancer	0.000187	0.00183	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—RARB—lung cancer	0.000187	0.00182	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—RARB—lung cancer	0.000187	0.00182	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—lung cancer	0.000183	0.00178	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NPPA—lung cancer	0.000182	0.00178	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NPPA—lung cancer	0.000182	0.00178	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	0.000181	0.00177	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HNRNPA2B1—lung cancer	0.000179	0.00175	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HNRNPA2B1—lung cancer	0.000179	0.00175	CbGpPWpGaD
Tazarotene—Rash—Irinotecan—lung cancer	0.000174	0.00189	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	0.000174	0.00169	CbGpPWpGaD
Tazarotene—Dermatitis—Irinotecan—lung cancer	0.000174	0.00189	CcSEcCtD
Tazarotene—RARB—Gene Expression—KHSRP—lung cancer	0.000171	0.00167	CbGpPWpGaD
Tazarotene—Rash—Gemcitabine—lung cancer	0.000169	0.00184	CcSEcCtD
Tazarotene—Dermatitis—Gemcitabine—lung cancer	0.000169	0.00184	CcSEcCtD
Tazarotene—Erythema—Methotrexate—lung cancer	0.000168	0.00183	CcSEcCtD
Tazarotene—Haemoglobin—Doxorubicin—lung cancer	0.000168	0.00183	CcSEcCtD
Tazarotene—Haemorrhage—Doxorubicin—lung cancer	0.000167	0.00182	CcSEcCtD
Tazarotene—RARG—Gene Expression—EIF2B5—lung cancer	0.000167	0.00163	CbGpPWpGaD
Tazarotene—Oedema peripheral—Doxorubicin—lung cancer	0.000165	0.00179	CcSEcCtD
Tazarotene—RXRB—Gene Expression—KHSRP—lung cancer	0.000164	0.0016	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—KHSRP—lung cancer	0.000164	0.0016	CbGpPWpGaD
Tazarotene—Pain—Docetaxel—lung cancer	0.000163	0.00177	CcSEcCtD
Tazarotene—Pruritus—Etoposide—lung cancer	0.000162	0.00176	CcSEcCtD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000162	0.00158	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NOTCH3—lung cancer	0.00016	0.00156	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.00016	0.00156	CbGpPWpGaD
Tazarotene—Pruritus—Paclitaxel—lung cancer	0.000159	0.00173	CcSEcCtD
Tazarotene—Rash—Cisplatin—lung cancer	0.000158	0.00172	CcSEcCtD
Tazarotene—Dermatitis—Cisplatin—lung cancer	0.000158	0.00171	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—APC—lung cancer	0.000157	0.00153	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CNDP2—lung cancer	0.000156	0.00152	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTM2—lung cancer	0.000156	0.00152	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	0.000155	0.00152	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000154	0.0015	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTM2—lung cancer	0.000154	0.0015	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—JUNB—lung cancer	0.000152	0.00148	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—DICER1—lung cancer	0.000151	0.00147	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—APC—lung cancer	0.000151	0.00147	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—EIF2B5—lung cancer	0.00015	0.00146	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	0.000149	0.00145	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	0.000146	0.00143	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	0.000146	0.00142	CbGpPWpGaD
Tazarotene—Erythema—Doxorubicin—lung cancer	0.000146	0.00158	CcSEcCtD
Tazarotene—Rash—Etoposide—lung cancer	0.000145	0.00157	CcSEcCtD
Tazarotene—Dermatitis—Etoposide—lung cancer	0.000144	0.00157	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—NOTCH3—lung cancer	0.000144	0.0014	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—EIF2B5—lung cancer	0.000143	0.0014	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—EIF2B5—lung cancer	0.000143	0.0014	CbGpPWpGaD
Tazarotene—Rash—Paclitaxel—lung cancer	0.000142	0.00154	CcSEcCtD
Tazarotene—Dermatitis—Paclitaxel—lung cancer	0.000142	0.00154	CcSEcCtD
Tazarotene—Discomfort—Methotrexate—lung cancer	0.000142	0.00154	CcSEcCtD
Tazarotene—CYP2C8—Biological oxidations—CYP2A7—lung cancer	0.000141	0.00138	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	0.00014	0.00137	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	0.00014	0.00136	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	0.000139	0.00136	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP2A7—lung cancer	0.000139	0.00136	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NOTCH3—lung cancer	0.000138	0.00135	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NOTCH3—lung cancer	0.000138	0.00135	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—JUNB—lung cancer	0.000136	0.00133	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—CDKN1A—lung cancer	0.000136	0.00133	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—DICER1—lung cancer	0.000135	0.00132	CbGpPWpGaD
Tazarotene—Pruritus—Docetaxel—lung cancer	0.000135	0.00147	CcSEcCtD
Tazarotene—CYP2C8—Arachidonic acid metabolism—CYP1A1—lung cancer	0.000134	0.00131	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	0.000133	0.0013	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000131	0.00128	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—JUNB—lung cancer	0.000131	0.00127	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—JUNB—lung cancer	0.000131	0.00127	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SKI—lung cancer	0.00013	0.00127	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—DICER1—lung cancer	0.00013	0.00127	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—DICER1—lung cancer	0.00013	0.00127	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTA3—lung cancer	0.000126	0.00123	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTA3—lung cancer	0.000124	0.00121	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	0.000124	0.00121	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	0.000123	0.0012	CbGpPWpGaD
Tazarotene—Discomfort—Doxorubicin—lung cancer	0.000123	0.00133	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	0.000122	0.00119	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—STAT3—lung cancer	0.000121	0.00118	CbGpPWpGaD
Tazarotene—Rash—Docetaxel—lung cancer	0.00012	0.00131	CcSEcCtD
Tazarotene—Dermatitis—Docetaxel—lung cancer	0.00012	0.0013	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	0.000119	0.00116	CbGpPWpGaD
Tazarotene—Oedema—Doxorubicin—lung cancer	0.000119	0.00129	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	0.000119	0.00116	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	0.000118	0.00115	CbGpPWpGaD
Tazarotene—Pain—Methotrexate—lung cancer	0.000117	0.00128	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	0.000117	0.00114	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SKI—lung cancer	0.000117	0.00114	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000116	0.00113	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTA4—lung cancer	0.000115	0.00112	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000115	0.00112	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	0.000114	0.00112	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTA4—lung cancer	0.000113	0.00111	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTA2—lung cancer	0.000112	0.00109	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SKI—lung cancer	0.000112	0.00109	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SKI—lung cancer	0.000112	0.00109	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	0.000111	0.00108	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTA1—lung cancer	0.000108	0.00105	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	0.000108	0.00105	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	0.000108	0.00105	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	0.000106	0.00104	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—RARB—lung cancer	0.000105	0.00102	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	0.000104	0.00102	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	0.000104	0.00102	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	0.000103	0.00101	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	0.000103	0.00101	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—AKR1C1—lung cancer	0.000102	0.000996	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NPPA—lung cancer	0.000102	0.000994	CbGpPWpGaD
Tazarotene—Pain—Doxorubicin—lung cancer	0.000102	0.00111	CcSEcCtD
Tazarotene—CYP2C8—Biological oxidations—UGT1A1—lung cancer	0.0001	0.00098	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	0.0001	0.000976	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	9.98e-05	0.000974	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	9.92e-05	0.000969	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—UGT1A1—lung cancer	9.9e-05	0.000967	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	9.88e-05	0.000964	CbGpPWpGaD
Tazarotene—Pruritus—Methotrexate—lung cancer	9.71e-05	0.00106	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	9.65e-05	0.000942	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	9.51e-05	0.000929	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	9.41e-05	0.000919	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	9.4e-05	0.000917	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	9.25e-05	0.000903	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NPPA—lung cancer	9.14e-05	0.000892	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	9.01e-05	0.000879	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—RARB—lung cancer	8.99e-05	0.000877	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—RARB—lung cancer	8.99e-05	0.000877	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	8.89e-05	0.000868	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NPPA—lung cancer	8.76e-05	0.000855	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—HSPB1—lung cancer	8.76e-05	0.000855	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NPPA—lung cancer	8.76e-05	0.000855	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	8.66e-05	0.000845	CbGpPWpGaD
Tazarotene—Rash—Methotrexate—lung cancer	8.66e-05	0.000941	CcSEcCtD
Tazarotene—Dermatitis—Methotrexate—lung cancer	8.65e-05	0.00094	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	8.65e-05	0.000844	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—HPGDS—lung cancer	8.54e-05	0.000833	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	8.52e-05	0.000832	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—lung cancer	8.48e-05	0.000828	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	8.46e-05	0.000826	CbGpPWpGaD
Tazarotene—Pruritus—Doxorubicin—lung cancer	8.41e-05	0.000914	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	8.29e-05	0.000809	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTT1—lung cancer	8.28e-05	0.000808	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GCLC—lung cancer	8.19e-05	0.000799	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP2A6—lung cancer	8.19e-05	0.000799	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	8.11e-05	0.000791	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—CREBBP—lung cancer	8.07e-05	0.000788	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—lung cancer	7.99e-05	0.00078	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	7.99e-05	0.00078	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HSPB1—lung cancer	7.86e-05	0.000767	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NOTCH3—lung cancer	7.72e-05	0.000753	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	7.66e-05	0.000748	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HSPB1—lung cancer	7.53e-05	0.000735	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HSPB1—lung cancer	7.53e-05	0.000735	CbGpPWpGaD
Tazarotene—Rash—Doxorubicin—lung cancer	7.5e-05	0.000815	CcSEcCtD
Tazarotene—Dermatitis—Doxorubicin—lung cancer	7.49e-05	0.000814	CcSEcCtD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	7.49e-05	0.000731	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	7.34e-05	0.000716	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—JUNB—lung cancer	7.31e-05	0.000713	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—CREBBP—lung cancer	7.24e-05	0.000706	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	7.1e-05	0.000693	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	7.04e-05	0.000687	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—POMC—lung cancer	7.02e-05	0.000685	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP2E1—lung cancer	6.96e-05	0.000679	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—CREBBP—lung cancer	6.94e-05	0.000677	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—CREBBP—lung cancer	6.94e-05	0.000677	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NOTCH3—lung cancer	6.92e-05	0.000676	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP2E1—lung cancer	6.87e-05	0.00067	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	6.81e-05	0.000665	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NOTCH3—lung cancer	6.64e-05	0.000648	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NOTCH3—lung cancer	6.64e-05	0.000648	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—JUNB—lung cancer	6.56e-05	0.00064	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—JUNB—lung cancer	6.29e-05	0.000613	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—JUNB—lung cancer	6.29e-05	0.000613	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	6e-05	0.000585	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	5.82e-05	0.000568	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	5.75e-05	0.000561	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTP1—lung cancer	5.74e-05	0.00056	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTP1—lung cancer	5.66e-05	0.000553	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—ERCC2—lung cancer	5.31e-05	0.000518	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTM1—lung cancer	5.28e-05	0.000515	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTM1—lung cancer	5.2e-05	0.000508	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP1A1—lung cancer	5e-05	0.000488	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP1A1—lung cancer	4.93e-05	0.000481	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—MYC—lung cancer	4.79e-05	0.000467	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—ERCC2—lung cancer	4.76e-05	0.000465	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—ERCC2—lung cancer	4.56e-05	0.000445	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—ERCC2—lung cancer	4.56e-05	0.000445	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AZIN2—lung cancer	4.4e-05	0.000429	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—COL4A3BP—lung cancer	4.4e-05	0.000429	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—MYC—lung cancer	4.3e-05	0.000419	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—MYC—lung cancer	4.12e-05	0.000402	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—MYC—lung cancer	4.12e-05	0.000402	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	4.1e-05	0.0004	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	3.97e-05	0.000388	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—CREBBP—lung cancer	3.89e-05	0.000379	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ATP5H—lung cancer	3.74e-05	0.000365	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—POMC—lung cancer	3.73e-05	0.000364	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—CREBBP—lung cancer	3.49e-05	0.00034	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	3.44e-05	0.000335	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—CREBBP—lung cancer	3.34e-05	0.000326	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—CREBBP—lung cancer	3.34e-05	0.000326	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLBD1—lung cancer	3.33e-05	0.000325	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.28e-05	0.00032	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HSD17B10—lung cancer	3.05e-05	0.000298	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CKB—lung cancer	2.83e-05	0.000277	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTM2—lung cancer	2.67e-05	0.00026	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CNDP2—lung cancer	2.67e-05	0.00026	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MTMR3—lung cancer	2.59e-05	0.000253	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PGAM1—lung cancer	2.53e-05	0.000247	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP2A7—lung cancer	2.41e-05	0.000235	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MAPK3—lung cancer	2.37e-05	0.000231	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SDC4—lung cancer	2.36e-05	0.00023	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MYC—lung cancer	2.31e-05	0.000225	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—RRM1—lung cancer	2.15e-05	0.00021	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTA3—lung cancer	2.15e-05	0.00021	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MAPK3—lung cancer	2.13e-05	0.000208	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MYC—lung cancer	2.07e-05	0.000202	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MAPK3—lung cancer	2.04e-05	0.000199	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MAPK3—lung cancer	2.04e-05	0.000199	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—B4GALT5—lung cancer	2.02e-05	0.000197	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MYC—lung cancer	1.98e-05	0.000194	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MYC—lung cancer	1.98e-05	0.000194	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTA4—lung cancer	1.96e-05	0.000192	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.92e-05	0.000187	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTA2—lung cancer	1.91e-05	0.000187	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTA1—lung cancer	1.85e-05	0.00018	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCC3—lung cancer	1.83e-05	0.000178	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AKR1C1—lung cancer	1.77e-05	0.000173	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—UGT1A1—lung cancer	1.72e-05	0.000168	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GNG11—lung cancer	1.66e-05	0.000162	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.65e-05	0.000161	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—AKT1—lung cancer	1.6e-05	0.000156	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALDOA—lung cancer	1.58e-05	0.000154	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NCOA3—lung cancer	1.53e-05	0.000149	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.5e-05	0.000147	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ADCY1—lung cancer	1.49e-05	0.000145	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCG2—lung cancer	1.49e-05	0.000145	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HPGDS—lung cancer	1.46e-05	0.000143	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ENO2—lung cancer	1.46e-05	0.000143	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPP2R1B—lung cancer	1.45e-05	0.000142	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—AKT1—lung cancer	1.43e-05	0.00014	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.43e-05	0.00014	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTT1—lung cancer	1.42e-05	0.000138	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GCLC—lung cancer	1.4e-05	0.000137	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP2A6—lung cancer	1.4e-05	0.000137	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.39e-05	0.000136	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—AKT1—lung cancer	1.38e-05	0.000134	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—AKT1—lung cancer	1.38e-05	0.000134	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ENO1—lung cancer	1.33e-05	0.00013	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.32e-05	0.000129	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.31e-05	0.000127	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP2E1—lung cancer	1.19e-05	0.000116	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NQO1—lung cancer	1.18e-05	0.000115	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.15e-05	0.000112	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.14e-05	0.000111	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—STK11—lung cancer	1.06e-05	0.000104	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.96e-06	9.72e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTP1—lung cancer	9.82e-06	9.58e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CAT—lung cancer	9.55e-06	9.32e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	9.5e-06	9.27e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCB1—lung cancer	9.29e-06	9.07e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—TYMS—lung cancer	9.13e-06	8.91e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTM1—lung cancer	9.02e-06	8.8e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP1A1—lung cancer	8.55e-06	8.35e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ERCC2—lung cancer	8.48e-06	8.28e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOA1—lung cancer	7.34e-06	7.16e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.03e-06	6.86e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CG—lung cancer	6.7e-06	6.54e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—POMC—lung cancer	6.38e-06	6.22e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CREBBP—lung cancer	6.21e-06	6.06e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CD—lung cancer	5.89e-06	5.75e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALB—lung cancer	5.81e-06	5.67e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CB—lung cancer	5.13e-06	5.01e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—lung cancer	5.09e-06	4.96e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTEN—lung cancer	4.44e-06	4.33e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—EP300—lung cancer	4.23e-06	4.13e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CA—lung cancer	3.13e-06	3.05e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AKT1—lung cancer	2.56e-06	2.49e-05	CbGpPWpGaD
